Healthpeak Properties (NYSE:DOC) Hits New 52-Week High Following Analyst Upgrade

Shares of Healthpeak Properties, Inc. (NYSE:DOC) hit a new 52-week high during trading on Thursday after Wells Fargo & Company raised their price target on the stock from $20.00 to $22.00. Wells Fargo & Company currently has an equal weight rating on the stock. Healthpeak Properties traded as high as $22.13 and last traded at $22.1050, with a volume of 342183 shares. The stock had previously closed at $21.74.

DOC has been the subject of several other research reports. Morgan Stanley restated an “equal weight” rating and set a $22.00 target price (up from $20.00) on shares of Healthpeak Properties in a research report on Thursday, June 11th. Royal Bank Of Canada upped their price target on Healthpeak Properties from $20.00 to $21.00 and gave the company an “outperform” rating in a research report on Thursday, May 14th. Raymond James Financial started coverage on Healthpeak Properties in a research note on Wednesday, June 17th. They set a “market perform” rating for the company. Citigroup lifted their price objective on Healthpeak Properties from $17.50 to $20.00 and gave the company a “neutral” rating in a report on Tuesday, May 12th. Finally, Robert W. Baird boosted their target price on shares of Healthpeak Properties from $19.00 to $21.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Four analysts have rated the stock with a Buy rating and fifteen have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $20.62.

Insider Activity at Healthpeak Properties

In other news, insider Scott R. Bohn sold 10,989 shares of the stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total transaction of $213,736.05. Following the sale, the insider directly owned 7,636 shares of the company’s stock, valued at $148,520.20. This represents a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.23% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Integrated Wealth Concepts LLC increased its stake in shares of Healthpeak Properties by 7.3% in the 1st quarter. Integrated Wealth Concepts LLC now owns 18,084 shares of the real estate investment trust’s stock valued at $366,000 after buying an additional 1,231 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Healthpeak Properties by 110.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 121,881 shares of the real estate investment trust’s stock valued at $2,463,000 after acquiring an additional 63,930 shares during the period. Woodline Partners LP lifted its stake in shares of Healthpeak Properties by 41.3% during the first quarter. Woodline Partners LP now owns 59,103 shares of the real estate investment trust’s stock valued at $1,195,000 after acquiring an additional 17,279 shares during the period. Brown Advisory Inc. boosted its holdings in Healthpeak Properties by 3.1% in the second quarter. Brown Advisory Inc. now owns 46,770 shares of the real estate investment trust’s stock valued at $819,000 after acquiring an additional 1,415 shares during the last quarter. Finally, Qube Research & Technologies Ltd bought a new position in Healthpeak Properties in the second quarter valued at about $3,117,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Stock Performance

The firm has a fifty day moving average of $20.41 and a 200-day moving average of $18.21. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15. The firm has a market cap of $15.38 billion, a P/E ratio of 69.71, a PEG ratio of 3.38 and a beta of 1.02.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.02. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The firm had revenue of $752.95 million during the quarter, compared to analysts’ expectations of $694.59 million. During the same period in the previous year, the business posted $0.46 EPS. The company’s quarterly revenue was up 7.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Research analysts predict that Healthpeak Properties, Inc. will post 1.75 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The firm also recently disclosed a monthly dividend, which will be paid on Friday, September 25th. Shareholders of record on Monday, September 14th will be paid a $0.1017 dividend. The ex-dividend date of this dividend is Monday, September 14th. This represents a c) dividend on an annualized basis and a yield of 5.5%. Healthpeak Properties’s dividend payout ratio (DPR) is presently 381.25%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.